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IMPROVEMENTS IN COMPUTED TOMOGRAPHY PERFUSION OUTPUT 
USING COMPLEX SINGULAR VALUE DECOMPOSITION AND THE 
MAXIMUM SLOPE ALGORITHM 
JASON A. FISHER 
ABSTRACT 
Objective:  Determine if complex singular value decomposition (cSVD) used as 
preprocessing in the maximum slope algorithm reduces image noise of resultant 
physiologic parametric images.  Noise will be decreased in the parametric maps of 
cerebral blood flow (CBF), cerebral blood volume (CBV) as compared to the same 
algorithm and data set with no cSVD applied.   
Materials and Methods: A set of 10 patients (n=15) underwent a total combined 15 CT 
perfusion studies upon presenting with stroke symptoms. It was determined these patients 
suffered from occlusions resulting in a prolonged arrival time of blood to the brain. 
DICOM data files of these patients scans were selected based on this increased arrival 
delay. We compared the output of estimation calculations for cerebral blood flow (CBF), 
and cerebral blood volume (CBV), using preprocessing cSVD against the same scan data 
with no preprocessing cSVD.  Image noise was assessed through the calculation of the 
standard deviation within specific regions of interest copied to specific areas of grey and 
white matter as well as CSF space. A decrease in the standard deviation values will 
indicate improvement in the noise level of the resultant images.. Results for the mean 
value within the regions of interest are expected to be similar between the groups 
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calculated using cSVD and those calculated under the standard method. This will indicate 
the presence of minimal bias. 
Results: Between groups of the standard processing method and the cSVD method 
standard deviation (SD) reductions were seen in both CBF and CBV values across all 
three ROIs. In grey matter measures of CBV, SD was reduced an average of 0.0034 
mL/100g while measures of CBF saw SD reduced by an average of 0.073 mL/100g/min. 
In samples of white matter, standard deviations of CBV values were reduced on average 
by 0.0041mL/100g while CBF SD’s were reduced by 0.073 mL/100g/min. CSF ROIs in 
CBV calculations saw SD reductions averaging 0.0047 mL/100g and reductions of 0.074 
mL/100g/min in measures of CBF. Bias within CBV calculations was at most minimal as 
determined by no significant changes in mean calculated values. Calculations of CBF 
saw large downward bias in the mean values. 
Conclusions: The application of the cSVD method to preprocessing of CT perfusion 
imaging studies produces an effective method of noise reduction. In calculations of CBV, 
cSVD noise reduction results in overall improvement. In calculations of CBF, cSVD, 
while effective in noise reduction, caused mean values to be statistically lower than the 
standard method. It should be noted that there is currently no evaluation of which values 
can be considered more accurate physiologically. Simulations of the effect of noise on 
CBF showed a positive correlation suggesting that the CBF algorithm itself is sensitive to 
the level of noise. 
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Introduction 
 Within months of the discovery of x-rays in 1895 the benefit of radiologic 
imaging was made clear to the medical community. Nearly 80 years later, on 
October 1, 1971, Sir Godfrey Hounsfield introduced computed tomography (CT) 
imaging. CT imaging has gone on to be an instrumental tool in the modern 
evolution of diagnostic medicine. The first CT scan acquired on that day complied 
an 80x80 pixel matrix of data in approximately five minutes, requiring an 
additional five minutes for processing, and resulting in a pixelated view of a 
frontal lobe tumor (Fig 1). By contrast, today’s scanners can acquire matrices of 
1024x1024 per slice, while acquiring multiple slices simultaneously, all in a time 
frame of less than 0.3 seconds (ImPACT, 2013), representing a 163-fold 
increase in data acquired in 1/1000th of the initial time. Computed tomography as 
a system functions by emitting radiation from an external source. This radiation is 
attenuated when it  passes through an object of interest, and  data relating to that 
attenuation is measured by the detector on the reverse side.  
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Fig 1. – First acquired CT scan. Atkinson Morley’s Hospital, Oct 1971. Displays Frontal lobe Tumor.  
 
Radiation of wavelength 20-50 pm, corresponding to energies approaching 100 
keV, is used in medical applications of CT. This level of radiation is considered 
‘Hard X-ray’ and approaches the upper limit of the x-ray portion of the 
electromagnetic spectrum. X-ray wavelength radiation is considered an ionizing 
radiation. As opposed to non-ionizing radiation, X-ray photons have sufficient 
energy to remove an electron from an atom or molecule. This may cause 
changes in a cell’s DNA and lead to eventual cell death or cancer development 
(American Cancer Society, 2010).  As such, radiation exposure and subsequent 
cancer development is a main source of concern when discussing the 
applications of CT to medicine. Patient exposure to radiation during a CT 
procedure can range from 2-10 mSv and can sum to 20-30 mSv for procedures 
involving multiple scans (Fred, 2004). For comparison, the average person is 
exposed to 2.9 – 4 mSv per annum as a result of background radiation (EPA, 
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2013). Background radiation includes terrestrial, cosmic, and unavoidable 
manmade sources of radiation in the environment. So while exposure is 
nominally low in medical applications, it can be seen that common imaging 
procedures may more than double an individual’s yearly dose. The extrapolation 
from radiation exposure to increased cancer risk is well documented throughout 
medical literature, however many studies focus on cohorts involved in large scale 
exposure such as atomic bomb detonation, nuclear reactor exposure, and 
uranium mines (American Cancer Society, 2010). Elucidating the risk of small 
scale exposure (<100 mSv), such as that in imaging procedures, has not been 
documented through current medical practice; the operating assumption is that 
risk is increased, however small, with increases in exposure (Mayo Clinic, 2013).  
 
Benefits of CT vs other imaging 
Computed Tomography, despite its flaws, has many benefits over other 
imaging modalities. Most often compared with magnetic resonance imaging 
(MRI), CT has faster scanning times, faster scanning preparation times, higher 
bone imaging quality, and a broader range of acceptable patients. Despite its 
high cost, CT images are often still half the price of MRI studies. Many of the 
other advantages to CT contribute to its ideal use for emergency imaging. CT 
studies have more flexibility with respect to any given patient’s medical history. 
As opposed to MRI, CT patients are not subject to constraints related to the field 
strength of a magnet. Therefore less time is required to evaluate patient medical 
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and surgical history for items such as pacemakers, surgical clips, pins, and any 
other magnetic items; and to further verify their magnetic safety. Coupled with the 
rapid acquisition time of CT imaging, these advantages result in a faster time 
from doorway to diagnosis in cases of acute emergency. For both MRI and CT, 
perfusion studies hold another advantage; they are functional images rather than 
structural. As a paradigm, dynamic imaging addresses the need for a 
visualization of the underlying pathophysiology (König, 2003).  
 
CT-Perfusion MR-Perfusion 
CTP advantages MRP Disadvantages 
    Linear relation of signal changes with 
contrast concentration; quantitative maps 
    Nonlinear relation of signal changes with 
gadolinium concentration; non-quantitative maps 
    Higher spatial resolution     Lower spatial resolution 
    More readily available     Not as readily available 
CTP Disadvantages MRP advantages 
    Ionizing radiation     No ionizing radiation 
    Limited z-direction coverage     Whole-brain coverage 
    Iodinated contrast–related concerns       
           
Table 1 - Adapted from “Theoretic Basis and Technical Implementation of CT Perfusion in Acute Ischemic Stroke, Part 1: 
Theoretic Basis” by A.A Konstas et al. 2009 
 
 
 
In evaluating CT versus MR in the context of perfusion studies, the above 
comparisons hold alongside additional measures. The underlying principles of 
perfusion in MR and CT are the same and result in the same clinical applications 
though differences in technique cast advantages to both sides. Fundamentally, 
CTP holds a strong advantage in that it is inherently quantitative throughout 
where as MRI relies on relative calculations (Konstas, 2009). This quantitative 
relationship in CT is due to the linear relationship between the concentration of 
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contrast and the attenuation of the CT beam. From this relationship CBF and 
CBV can be calculated empirically. In MRP, the indirect effect of the gadolinium-
based contrast in shortening the T2 length is what creates the detectable 
contrast to noise ratio and is not linear with respect to the contrast concentration 
(Konstas, 2009). Until recent scanner iterations, coverage of the whole brain was 
not often possible in CTP giving MRP an advantage. In the latest generations of 
CT scanners this is no longer the case. 
 
Stroke and CT Imaging 
Considerations on the time frame of treatment are highlighted best in 
cases of acute stroke. Stroke, also referred to as a cerebrovascular accident 
(CVA), is a decrease or loss of the blood supplying the brain tissue leading to a 
decrease in brain function. This can be due to a loss of flow, usually by 
occlusion, known as an ischemic stroke; as well as a loss of blood volume in the 
case of a bleed, known as a hemorrhagic stroke. Long term effects of strokes are 
wide ranging and vary greatly. Since damage is initially caused to focal areas of 
brain tissue, the exact location of the damage may elucidate different effects. For 
example an infarct occurring on the right side of the brain may result in 
symptoms on the left side of the body (American Stroke Association, 2012). The 
most common effects of stroke include physical dysfunction such as hemiparesis 
or paralysis and disturbances to vision, cognitive dysfunction such as aphasia 
and memory loss, as well as the resulting lifestyle changes associated with these 
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conditions. While location dictates the effects a stroke survivor may suffer, the 
severity of these effects are predicated on the amount of damage done to the 
tissue. As the amount of blood delivered to the brain tissue decreases the tissue 
begins to lack the energy required to continue normal processes. Within hours 
inflammation of the tissue leads to apoptotic cell death. As time passes more and 
more tissue is deprived of its essential blood supply and begins to die. In cases 
of stroke, the brain tissue that has already died is referred to as the infarct or 
infarct core. This tissue is unsalvageable and may be the cause of permanent 
damage and symptoms such as those listed above. Acute stroke treatment aims 
for salvation of the penumbra, or ‘partial shadow’, referring to the brain tissue 
surrounding the infarct which is at risk, but not yet dead (Wintermark, 2006). It is 
for this reason that time is the most important factor in successful treatment. CT 
scanning arises as the optimal imaging modality by minimizing the time required 
to put the patient’s information into the physician’s hands. After entering the door 
at Boston Medical Center, patients are expected to be in the CT scanner within 
25 minutes and have their results interpreted within an additional 20 minutes 
(Table 2). This is possible due to the lack of screening for magnetic safety as 
present in MRI as well as the reduced scanning time. A 2002 study by 
Wintermark et al. placed the time difference between onset of symptoms to scan 
results at +30 minutes for MRI protocols as compared to CTP (Wintermark, 
2002).  
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Emergency Department Stroke Care Process Measure Assessment Tool 
Activity Time 
Targets 
Door to notification of Acute Stroke Team (AST),  within 5 
minutes 
of arrival 
Time from notification of AST to response of team member by phone or at patient 
bedside to assess patient 
within 5 
minutes 
of being 
called 
Door to CT scan or MRI scan within 25 
minutes 
Door to CT result within 45 
minutes 
Door to completion of chest X-Ray and interpretation within 45 
minutes 
Door completion of ECG and interpretation within 45 
minutes 
Door to completion of labs and results/interpretation within 45 
minutes 
Results (labs, CT) to tPA decision time* Within 10 
minutes 
ED door-to-needle time for IV thrombolytic (t-PA) treatment within 60 
minutes 
Time from order of neurosurgical evaluation to start of evaluation; includes transfer 
to another hospital for such evaluation, if applicable 
within 2 
hours of 
being 
deemed 
clinically 
necessary 
Neurosurgical intervention as 
needed 
urgently 
Table 2 - *DPH Stroke Care Reccomendations modified for BMC. Adapted from http://www.bmc.org/stroke-
cerebrovascular/services/acute-stroke-protocol.htm 
 
The frontline treatment for ischemic stroke is recombinant tissue plasminogen 
activator (rtPA). Normally located on endothelial cells, tPA catalyzes 
plasminogen’s conversion to plasmin via pepsidase activity at the Arg-Val bond 
(ExPASy Swiss Insitute of Bioimformatics, 2013). Plasmin then acts as the major 
enzyme in destroying fibrin within a clot, and in cases of stroke thereby restores 
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perfusion of blood to the brain tissue. IV administration of tPA in acute ischemic 
stroke is limited to a maximum of three hours after onset of symptoms (FDA, 
1996). As such, minimizing evaluation time is a priority and a prerequisite for 
efficacious treatment. This 3 hour window has been established by the National 
Institute of Neurologic Disorders and Stroke in their landmark 1995 study on rtPA 
in stroke (NINDS, 1995). From the moment of onset of stroke symptoms the risk 
of an intracranial bleed begins to rise. At the same time, the infarcted area begins 
to grow and some tissue is marked as unsalvageable. At three hours after the 
onset of symptoms the infarct is sufficiently established, and the risk of 
intracranial bleeding is high enough such that the benefit of lowering the clotting 
capacity was no longer a viable option against the chance of hemorrhage 
(NINDS, 1995). The NINDS study, and the subsequent guidelines for tPA use 
include many other exclusion criteria. A patient eligible for treatment with rtPA 
must have blood pressure below 185/110 mmHg, have a CT scan showing no 
sign of blood within the brain, not have a hereditary disposition for bleeding 
disorders, and could not be showing quickly improving signs or lack a 
measureable score on the National Institutes of Health Stroke Scale (Zivin, 
2009). It is evident that these criteria are severely limiting, only an average of 3% 
– 8.5% of stroke victims in the United States receive tPA (Reeves, 2005). 
Particularly disconcerting are cases of stroke which do not receive treatment 
based on rapidly improvement of initial symptoms. A study in 2001 following 
patients presenting within the three hour window found that while 27% (n = 314) 
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of patients were treated, a further 31% were excluded due to mild or improving 
symptoms. 1/3 of the excluded patients (10% of n) deteriorated to dependent 
states of living or death (Barber, 2001). A further prospective study mirrored the 
results in that 34% of patients within the three hour window (n=128) were not 
treated with IV tPA after having been deemed ‘too good to treat’. In follow up 
27% of those patients died or were not discharged due to worsening neurological 
status (Smith, 2005). While patients evaluated in these studies arrived within the 
FDA approved three hour window, a majority of patients do not, and are therefore 
excluded from treatment. In addressing these outcomes, recent years have seen 
physicians and hospital protocols adopting off-label use of tPA within an 
extended three to four and a half hour window. In 2009 a science advisory group 
of the American Heart Association (AHA) stroke council provided a class one 
recommendation (Benefit >>> Risk) of tPA use in the three to four and a half hour 
window. Citing results of the European Cooperative Acute Stroke Study (ECASS-
3) the council determined that while their conclusions were based on only one 
randomized trial patients should be administered IV rtPA within the three to four 
and half hour window from symptom onset if they meet additional criteria 
compared to those outlined for the three hour treatment window (Del Zoppo, 
2009). These additional qualifications dictate the patient should be under the age 
of 80, should not be taking oral anticoagulants and have an international 
normalized ratio (INR) of less than or equal to 1.7, should have a National 
Institutes of Health Stroke Scale (NIHSS) score of less than 25, and must not 
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have a history of combined stroke and diabetes mellitus. The study included 
groups of rtPA patients (n=418) and placebo patients (n=403) presenting 
between three and four and a half hours. With the exception of the additional 
criteria listed above, the study followed AHA guidelines outlined for tPA treatment 
within the three hour window. The primary efficacious outcome, a modified 
Rankin Scale score of zero or one 90 days post treatment was seen in 52.4% of 
rtPA patients and 45.2% of placebo patients, representing a statistically 
significant outcome (Del Zoppo, 2009).   
 
Managing Time in Acute Stroke Treatment 
Many time points are evaluated between onset of symptoms and eventual 
treatment. These criteria are used to determine courses of treatment as well as 
minimize the time to treatment and are integrated into departmental protocols on 
a hospital by hospital basis. With respect to imaging, four time points are 
recommended by a recent symposium consisting of leading physicians and 
imaging specialists along with members of the FDA and relevant NIH 
departments. At baseline presentation, either an MRI or CT study will be 
performed and include non-contrast CT, CT perfusion, and CT angiography 
including the cervical and intracranial arteries (Wintermark, 2008). MRI baseline 
studies will include a localizing scout scan, diffusion weighted imaging (DWI), 3D 
time of flight MR angiography (MRA), gradient recalled echo images (GRE), 
perfusion weighted images (PWI), and T2 fluid attenuated inversion recovery 
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images (T2 FLAIR) with or without gadolinium based contrast (Wintermark, 
2008). From one to six hours after treatment follow up scans (CT or MRI) should 
be administered to monitor treatment efficacy.  Athird imaging set should be 
acquired with the goal of determining treatment safety especially with regard to 
hemorrhagic transformation and a fourth as a follow up to determine the final 
infarct volume and distribution (Wintermark, 2008). 
 
Background on computer processing algorithms for CT 
Owing its birth to the advent of computers, CT imaging has continued to 
grow alongside the sophisticated processing power of today’s machines. This is 
evident with an understanding of the computers role in CT. Tomography refers to 
imaging by sections and is manifest in the acquisition and output of a CT scan 
which is composed of cross sectional images known as ‘slices’. These slices 
represent a two dimensional view, of designated thickness, which when stacked 
will produce the imaged volume. Depending on the region of interest (ROI) and 
cause for the study, output may be presented as a three dimensional volume as 
well as two dimensional images of varying depth. These slices are produced by 
positioning the beam at varying angles with respect to the object of interest. 
Typically images are acquired at one degree intervals over a 180 degree arc. 
The collected data represents information relevant to the level of attenuation of 
the x-ray beam as it passes through the body. X-rays are particularly sensitive to 
the varying attenuation properties of tissue. For example the high attenuation of 
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bone relative to fat or other tissues results in the clear delineation of joints. This 
difference in the data collected is directly related to the attenuation coefficient, a 
tissue-specific property most closely related to the tissue density. The 
interpretation of this data is based on the line integral of the X-ray attenuation 
coefficient along the path of the beam (Deuflhard, 2009). The Radon transform 
developed by Johann Radon, an Austrian mathematician, represents the integral 
equation of the attenuation coefficient and is used as the basis for today’s 
computer processing of CT images. A large hurdle for the development of these 
formulae into working algorithms concerned a problem in variability. Inverse 
problems are those in which errors in input data, which are unavoidable, 
propagate into extreme errors in output. Phenomenon such as beam hardening, 
in which the low energy photons are absorbed quickest, produce the nonlinearity 
of the attenuation coefficient (Brooks, 1976). Problems such as this give rise to 
the pursuit of striking a balance between filtering out noise and retaining the 
highest possible resolution. Optimizing the scan data takes place in two distinct 
steps. Firstly data is filtered to remove the highest frequency data, considered an 
unwanted signal of low attenuation. This filtering makes use of discrete 
convolution in two dimensions and Fourier transforms in three and four 
dimensional scans (Deuflhard, 2009). The second step is a back projection of the 
data on to the reconstruction dimensions. This step blends the acquired and 
filtered data back through its original path resulting in a representation of the 
original object. Given an infinite number of views and data points per view of an 
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object the filtered back-projection method produces an image identical to the 
physical case (DSP, Smith Ch 25). This is not the case in practical medical 
imaging. 
 
Background on CTP and Algorithms Specific to CTP 
 While CT imaging was developed as a modality for structural imaging, 
many dynamic and functional techniques have become common place. CT 
angiography (CTA) provides a view of flow through vasculature of interest, while 
CT perfusion (CTP) attempts to map the blood flow to regions of the brain at the 
level of the capillaries. This paper will focus on CTP as the main modality of 
discussion. As mentioned previously perfusion CT adds a view of the underlying 
pathophysiology to the evaluation of acute ischemia. Specifically CTP addresses 
the questions of whether a critical ischemic core of infarcted tissue exists, and 
whether a potentially salvageable penumbra around that core is present 
(Konstas, 2009). Perfusion studies present this data in a set of parametric maps 
(Fig 2) which provide views into their respective underlying parameters. Cerebral 
Blood volume (CBV) represents the volume of blood flowing through any given 
portion of the brain. CBV is measured in milliliters per 100g of brain tissue and 
represents the level of vasodilation. Cerebral Blood Flow (CBF) is the volume of 
blood flowing in a given volume over a given time and is measured as a rate in 
milliliters per 100g tissue per minute. The CBF reflects the amount of oxygen and 
other nutrients being delivered to the area and contributes to the determination of 
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infarct vs penumbra regions (Bivard, 2011). In cases of ischemic stroke there is a 
rapid loss of CBF to the tissue around the infarct. In an attempt to compensate, 
CBV is increased to restore blood to the area. As time passes, swelling in the 
area can compress blood vessels resulting in a decrease of CBV (Barber, 1998). 
This compression may also be caused by a failure of the auto regulation capacity 
of the vasculature (Bivard, 2011). Two other important parameters highlight flow 
with respect to time rather than concentration. Mean Transit Time (MTT) 
represents the average time blood takes to travel through a given region of tissue 
and is the most direct indicator of occlusion and penumbra identification 
(Konstas, 2009). Most often MTT is calculated as the ratio of CBF to CBV. Time 
to Peak (TTP) is a measure, in seconds, of the time before the greatest 
concentration of contrast arrives in a given area. Often a mismatch map will be 
generated from the parameters MTT and CBV. A high MTT is indicative of 
penumbral tissue while a decreased CBV highlights the established infarct. A 
subtraction of the these two parameters results in the best image of salvageable 
tissue (Bivard, 2011). Common thresholds are MTT maps of 145% and CBV 
boundaries of less than 2ml/100g (56%) (Wintermark, 2006). While commonly 
used, these values are not quantitatively valid across multiple scanners and 
processing software. Establishing these quantitative thresholds is a current focus 
for the field of CT perfusion research. 
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Fig 2 –Visualization of CTP measurements and Parametric Data. Adapted from Medscape Article 742007_7 (Bivard Et al, 
2011) 
 
As early as 1980, cerebral blood flow analysis by CT had been outlined, 
and the mathematics constructed, by Leon Axel (Axel, 1980). While the theory 
was advancing the clinical context of CTP was limited by slow acquisition as well 
as slow post-processing computations for several years (Konstas, 2009). Image 
acquisition relies on several input conditions for the scanner, foremost among 
them is the rate at which images are acquired. Initial protocols were designed to 
acquire one image every second for 45 seconds (Wintermark, 2008). This 
interval was introduced to minimize radiation dose by minimizing scan time. 
However, reducing the scan time is forever coupled to the risk of capturing 
incomplete data relating to the concentration of contrast in the tissue. The risk is 
increased when dealing with low cardiac output or occlusion as seen in cases of 
acute ischemia. This time activity curve (TAC) is a main point of computation as 
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we will see in following sections and may result in poor scan results if relevant 
sections of the curve are omitted. In considering this risk, scan times are 
recommended at a minimum of 60 seconds and typical values fall between 70 
and 90 seconds (Wintermark, 2008). With patient exposure in mind a 
compromise between longer acquisition times and radiation dose was reached 
by dividing the acquisition into two phases and three phases for longer protocols 
such as blood brain barrier permeability scanning (Wintermark, 2008)(Table 3) In 
the first phase, images are acquired at a rate of 1 image per second. This phase 
ranges from 30 to 45 seconds in duration. In phase 2 one image is acquired 
every other second or every three seconds. Again this phase endures for 30 to 
45 seconds resulting in an overall scan time of 70 to 90 seconds (Wintermark, 
2008). Using this protocol the scan maintains its sensitivity to the full duration of 
the contrast bolus transit time and results in minimal radiative dose by capturing 
snapshots of the later transit times. This method maintains appropriate quality of 
data acquisition due to the fact that changes in the contrasted tissue occur less 
rapidly in the latter stages of the contrast’s presence (Miles, 2003).   
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Image 
acquisition 
rate 
2 phases: 
 1st phase: 1 image per second, duration=30 to 45 seconds 
 2nd phase: 1 image per 2 to 3 seconds, duration=30 to 45 seconds 
 Total duration of the acquisition at least 70 to 90 seconds 
Gantry 
rotation 
1 second per gantry rotation (up to every 3 seconds with “shuttle” or “toggle 
table” mode) 
Image 
acquisition 
parameters 
80 kVp, 100 mAs 
Coverage and 
slice 
thickness 
Maximal coverage possible based on CT scanner configuration (minimal 
coverage of 20 mm slab per contrast bolus injection preferable; two boluses is 
suggested to double coverage for all CT scanners with under 4 cm detector 
length unless precluded by contrast dose considerations) focus on supratentorial 
compartment/anterior circulation 5- to 10-mm-thick slices field of view ≈24 cm 
Slice 
orientation 
Parallel to hard palate lowest slice through the proximal middle/anterior cerebral 
artery (above the orbits) 
Contrast 
material 
350 to 370 mg/mL iodinated contrast material high concentration, low/iso 
osmolar contrast preferred follow local guidelines for contrast-induced 
nephropathy prevention 
Contrast 
volume 
35 to 50 mL, followed by 20 to 40 mL saline flush 
Injection rate 4 to 6 mL per second (power injector required) same injection rate for contrast 
and saline 
Table 3 – Recommended Acquisition Parameters. Adapted from “Special Report of the Acute Stroke Imaging 
Research Roadmap”,  2008. 
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Also implemented as a measure to limit radiation dose, the current and 
voltage measurements of image acquisition are reduced in CTP as compared to 
structural CT. Recommended by the Special Report of the Acute Stroke Imaging 
Research Roadmap are voltages of 80 kVp and current of 100 mA, though 200 
mA parameters are also typical (Konstas, 2009). Dynamic perfusion imaging 
requires many more slices of the target to be acquired as compared to CT. As 
ntoed this increase in data collected brings with it increased radiation exposure 
as a consequence of time on the scanner table. By reducing the peak voltage of 
the X-ray tube, the exposed dose is brought down to levels seen in typical 
structural CT (Nabavi, 1999). At a given unit of current (mA) contrast enhanced 
CT (both structural and dynamic) has greater opacity at 80 kVp than the standard 
120 kVp protocol (Konstas, 2009). This is due to the greater contribution of the 
photoelectric effect between the X-ray beam and the contrast agent consisting of 
iodine as opposed to non-contrast CT, in which Compton scattering dominates 
(Wintermark, 2000). The binding energy of the K shell (1s level) electrons in 
iodine resides at 33.2 KeV (Abudurexiti, 2010). In the photoelectric effect 
incoming photons are absorbed and electrons released from the interacting 
medium, in this case the iodinated contrast. This results in a sudden jump in the 
attenuation coefficient of the diagnostic beam. Only photons with incoming 
energies above the K shell binding energy levels (K-edge) will be attenuated, 
with preference shown to those photons whose energy is above, but near the 
iodine K-edge. The sudden attenuation of the beam enhances the difference in 
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contrast between areas with and without the iodinated material. In terms of 
perfusion CT, ultimate benefits of lower effective dose as well as enhanced 
visualization of blood flow are seen due to the stark difference in beam 
attenuation collected at the detector.  
 Once the scanning acquisition is complete, the collected data is 
transferred to a dedicated workstation to begin processing into parametric data. 
Clinically, multiple software developers offer products for data processing, some 
are fully automated while others require some user input (Konstas, 2009). As 
mentioned previously these packages have poor validity across scanner types, 
operators, and processing methods and many projects are underway to develop 
a standard method. As an essential step, data from irrelevant structures is 
removed from the scan. The process of image segmentation involves identifying 
areas of little interest including arteries and veins as well as non-cerebral tissue 
and bone. Processing algorithms single out this data based on a threshold of 
attenuation. Different tissues have characteristic ranges of attenuation of the X-
ray beam. Bone, fat and air can all be segmented out by removing those voxels 
with measurements of less than zero or greater than 60-80 Hounsfield Units (Hu) 
(Miles, 2007) (Table 4).  
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Table 4 – Houndsfield Scale. Adapted from lecture on CT physics at http://www.codeproject.com/Articles/466955/Medical-
image-visualization-using-WPF 
 
The Hounsfield scale describes the radiodensity of a given material based 
on the attenuation coefficient of distilled water, defined as zero on the Hounsfield 
scale. A linear transformation of the measured attenuation coefficient provides 
the conversion to Hounsfield units  such that an increase or decrease of 1 Hu 
mirrors a 0.1% change in the attenuation coefficient of water in the same 
direction.  Following segmentation and subsequent choosing of a region of 
interest both an artery and vein must be selected to serve as input and output 
functions respectively. This may be selected automatically by the software but 
should always be manually verified.. The arterial input function (AIF) represents 
the ‘wash in’ period of contrast transit and is required to perform deconvolution 
analysis.. The venous output function (VOF) is needed quantitatively to normalize 
the AIF values and correct for any partial volume effects (Sanelli, 2004). Partial 
volumeing occurs when an individual voxel contains both tissue and vessel.. In 
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choosing an AIF, often voxels along the border of the vessel will exhibit these 
effects. To minimize the consequence of partial volume voxels, irrespective of 
VOF correction, care should be taken to select an AIF orthogonal to the plane of 
the ROI. Minimizing slice thickness will also aid in reducing partial volume 
effects. With respect to VOF choice, selection of a small deep vein will 
overestimate parametric values of CBV and CBF by a factor of two to three 
(Sanelli, 2004). An analogy can be made to a clogged drain in which more water 
is attempting to leave the system than the drain can maintain, resulting in a 
backup of water, an overestimation of the expectated of water in the sink. For this 
reason often the superior sagittal sinus (SSS) is chosen as the VOF. A large 
assumption underlies calculations of perfusion based on arterial input functions, 
that is that the AIF is the sole input to the ROI tissue. Clinically, additional 
vasculature, potential occlusion, and irregular cardiac output may result in delay 
and dispersion of contrast material and by extension, blood flow in which the AIF 
shows lag followed by lag in the tissue contrast (Fig 2). Effects of delay and 
dispersion on calculations result in large underestimations of CBF and 
overestimations of MTT (Konstas, 2009).  
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Fig 3 – Illustration of Potential for dispersion. Adapted from Gupta, 2010 Presentation to AAPM Technology Assesment 
Institute: Summit on CT Dose 
 
An additional area of investigation is whether choosing an AIF ipsilateral 
or contralateral to the affected hemisphere has an effect on values of CBV and 
CBF. A 2007 study by Bisdas et al. determined AIFs selected either ipsilateral or 
contralateral to the infarcted region produced CBV and CBF values with good 
correlation. The study did not specifically address severely stenotic or disrupted 
cardiac output patients which may contribute to delay effects.  
 
Calculations of CBV based on Tracer Kinetics 
Cerebral Blood Volume determination is a cornerstone of the quantitative 
processes in CTP and precedes a difference in modeling for CBF and MTT. 
While necessary for calculation of additional parameters, CBV itself is predicated 
on tracer-kinetic theory (TKT). TKT states that with respect to a known volume, 
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one can determine the distributed volumes and clearance rate of a substance 
flowing through the bounded areas with measurements of the input and output of 
the substance (Konstas, 2009). In the context of CTP, an individual voxel stands 
as the bounded region, with the input represented as blood flow, including 
contrast material, into the area and output by the washout of blood from the 
voxel. The volume of distribution of blood within the voxel is denoted f for 
fractional vascular volume. 
   	
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Clearance rate is measured in flow per unit volume (Konstas, 2009). This fraction 
represents the scaling factor seen between contrast concentrations in a region of 
tissue as compared to an area of vasculature.  
	
	   	  
Tissue concentration will always be a lower value than concentration in the 
vasculature based on the main assumption of the theory as applied to CTP; that 
is the tracer material is not diffusible along its path. Nor does the tracer become 
absorbed by tissue, metabolized, or in any way deteriorate along a first-pass. 
This assumption holds as long as no disturbance to the BBB exists (Konstas, 
2009). Given this assumption of TKT, perfect conservation of mass should exist 
in the model and will serve for the basis of the CBV calculation. Keeping in mind 
the above conditions, it holds that contrast entering the tissue should correspond 
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with a decrease in concentration in the supplying artery. In addition a wash-in 
period exists such that incoming tracer is not immediately removed. Instead 
tissue concentration begins to rise before venous outflow is established. We can 
model the component of the flow that is contrast into the tissue region by 
multiplying the incoming flow of blood (CBF) with the decreasing contrast 
concentration in the artery over time. 
	   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As defined by the first principle of conservation of mass the blood leaving the 
tissue must account for the total mass of blood entering the tissue. We can 
model the outflow in the same fashion as the flow into the tissue. In this case the 
concentration in the tissue becomes the decreasing quantity as the concentration 
in the vein increase. 
	   	  
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In order to determine the CBV from the theoretical yield calculated here, the 
value must be adjusted for the attenuation of brain tissue as well as a factor 
  
correcting for the difference in hematocrit between the tissue (capillaries) and 
arteries (Calamante, 1999) (Konstas, 2009). 
out TAC as the area under the curve (AUC) for the region of interest (
Fig 4 - Time Activity Curve. Adapted from Gupta, 2010, Presentation to AAPM Technology Asses
CBF 
 Calculations of CBF are subsequent to the choosing of a model for blood 
flow. The main techniques can be divided into clas
and non-deconvolution based methods. In many ways the two methods are 
comparable, both are based on conservation of mass for example, though 
differences do exist. Deconvolution calculations are significantly more demanding 
in both theory and execution, and these calculations call for lengthier processing. 
Non-deconvolution techniques are built upon simplified assumptions which have 
created the opinion that it is a less accurate technique (Wack, 2012). However in 
comparisons of the two approaches no clinical validation of either technique has 
been elucidated. Also of note is that convolution theory as applied to CTP, while 
25
CBV can also be defined from the 
s
on CT Dose. 
ses based on deconvolution 
Fig 4).  
 
ment Institute: Summit 
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less presumptive, has not been shown to produce stable solutions and often 
generates a non-sensical impulse function (Wack, 2012). In the study described 
the author will utilize non-deconvolution based computation by choice to illustrate 
the efficacy of the noise reduction method. Both techniques will be explained in 
this section 
 
Maximum Slope Algorithm, a Non-Deconvolution approach 
As described earlier, conservation of mass, assuming no dispersion, 
results in the tissue contrast (mass) being the product of the blood flow and the 
integral over time of the difference between AIF and VOF. 
$    % & '	(  
Cartery and Cvenous represent the concentrations entering and leaving the tissue, 
respectively. In the maximum slope method, a main assumption comes into play. 
That is, during measurement no contrast has reached the venous side of the 
circulation. This ‘no venous outflow’ assumption arises from the maximum slope 
method’s original use with radiolabeled microspheres which were removed in a 
first pass through the tissue (Wintermark, 2001). The iodinated contrast of CT is 
not removed in this way and so this assumption is a necessary compensation. To 
meet this assumption in the clinic, patients would need to be subjected to 
contrast injection rates of approximately 10 mL/s (Leiva-Salinas, 2011). Through 
a peripheral IV, this flow rate is not attainable in nearly all cases due to 
discomfort to the patient and/or damage to the vessel (Leiva-Salinas, 2011) The 
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resulting effect of the inherent violation of this assumption will be an 
underestimation of CBF values (Leiva-Salinas, 2011). With respect to the 
conservation of mass integral this assumption holds for t < 7s after injection 
(Konstas, 2009). The conservation equation becomes simplified to disregard the 
venous concentration function. 
$      
This equation represents a single compartment model (Mullani-Gould 
formulation) described by Nizar Mullani and Lance Gould in the early 1980s 
(Mullani, 1983). A simple derivative of this new equation allows for 
straightforward calculation of CBF. 
 $   )  
At any given moment in the system cerebral blood flow can be assumed to 
remain a constant. Therefore we can see that the derivative of the maximum 
contrast mass in an area of tissue is related to the rate of change of contrast in 
the supplying artery. The ratio of these maximums will yield the cerebral blood 
flow value for the voxel. As can be seen here, the above steps are few in number 
and not mathematically cumbersome, allowing for the rapid calculation of 
perfusion parameters by the software, the chief advantage of the maximum slope 
method.  
  
Fig 5 – visualization of input to Maximum Slope Algorithm
Models Based on Deconvolution
Computation based on deconvolution seeks to mirror the flow of blood into 
tissue without relying on simplification. This approach has presented a host of 
challenges with regards to the stability of any given solution. As before 
calculations are performed b
deconvolution approach, attention is first given to the mean transit time. The MTT 
is defined as the time required for one blood cell to enter and exit the volume of 
interest. Since within a given volume multitude
travel, and therefore a multitude of potential travel times, a stationary distribution 
of probability is established and labeled 
moment of the distribution.
28
. Adapted from Konstas et. al, 2009
 
 
ased on a given volume of interest. In the 
s of pathways exist for a cell to 
h(t). The MTT is calculated as the first 
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The deconvolution takes place next to derive a function to specify the residual 
contrast in the volume of interest at an intermediate time. The so-called residual 
function R(t) is a quantitative value of the contrast in the tissue from the moment 
of arrival onward (Fieselmann, 2011). The function exhibits an instantaneous rise 
to 1 at the arrival of the bolus and decay thereafter as contrast leaves the 
volume. The decay is modeled on the previously derived MTT.  
.  /1 &   , ,  2 00 ,                                  4 05 
The residual function is based on the arrival of an idealized bolus represented as 
a Dirac delta function.  The concentration of contrast in the tissue can be 
formulated as a convolution of the AIF and the residual function (Meier & Zierler, 
1954).  
	  6789.: 
In the above approximation the tissue contrast and AIF are known values from 
the CTP cine data. The solution of R(t) and subsequent calculation of CBF can 
be achieved through many available methods. The parametric solution is 
obtained by restricting the shape for R(t) and solving for CBF. This technique 
avoids the irrational output of the residue function, which is a component of 
overall noise, but is based on knowledge that could not be known prior to 
calculation with enough precision to produce reliable results (Ostergaard, 1996). 
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For these reasons parametric approaches are largely unused. The opposing 
category, nonparametric solutions, avoids assuming a solution to R(t). Instead 
the residual is computed and further techniques are implemented to handle the 
irrational nonphysiological values produced. The first technique deconvolves the 
original equation using Fourier transform properties. The Fourier transform as 
applied to convolution states that the convolution of any two functions in the time 
domain is equivalent to the multiplication of those functions in the frequency 
domain (Gobbel, 1994) and vice versa. Since the Fourier transform converts 
functions between these domains the convolution theorem can be written simply 
as 
6)9;:  ) < ; 
Therefore the CBF and residual can be determined by applying the inverse 
transform to the ration of the measure quantities, AIF and Ctissue (Konstas, 2009). 
Alternatively, the singular value decomposition (SVD) method can be applied to 
CTP calculations and is the most common technique (Konstas, 2009). SVD 
decomposes a given matrix (Y) into three component matrices defined as an (1) 
mxm unitary matrix (U), (2) mxn diagonal matrix (S), (3) nxn unitary matrix (V*) 
(Wack, 2012). 
=  >?@ 
Creation of an algebraic form of the original deconvolution equation will yield 
matrices of the form - 
78 < .  	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Matrix adapted from Theoretic Basis and Technical Implementation of CT Perfusion in Acute Ischemic Stroke Part 2. 
Konstas, 2009 
 
In searching for a solution to R(t), singular value decomposition is applied to the 
AIF matrix. We decompose A to find- 
7  >?@  A "BC@DE  
Where ui and vi* are orthogonal vectors (Fieselmann, 2011). The matrix rank r of 
A is determined by the number of leading digits determined to be zero in the AIF 
series AIF(t) t = 1,……N, therefore r ≤ N - Nzeros (Fieselmann, 2011). The 
resulting component matrix Si is a diagonal matrix containing the singular values 
of the system. To find a solution to the over determined residual equation, R(t), 
the common approach is the least square solution. The least squares solution 
seeks to minimize the sum of squares error of each solved equation (Golub, 
1996). The least squares solution of R(t) by the pseudoinverse of A is most easily 
illustrated using our previous abbreviated notation 
78 < .  	 
Which will be further simplified to - 
7.   
.  7  7FE 
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Having applied singular value decomposition we know A to be comprised of 
components U, S and V*. We have need now of the pseudoinverse of A which 
will similarly be comprised of the components U*, Sinv, and V. Sinv receives 
separate notation due to its potential for not being a true inverse. As the singular 
values of S closely approach zero their inverse values will tend to positive or 
negative infinity (Wack, 2012). Continuing from above –  
.
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The least squares solution does not represent an adequate solution for ill-posed 
problems (Fieselmann, 2011). For Toeplitz matrices  of ill-conditioned problems a 
minute change in c, due to noise, will propagate a large change in the residual 
function defined as s1/sr (Golub, 1996). As such we can see that noise still 
dominates our solution. Many techniques exist for filtering noise from this point in 
the methodology forward, including the focus of this study.  
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Fig 6. – Simulated Impulse Functions R(t). From left to right – singular values truncated at 0.01, 0.1, 0.3, 0.4. Noise was 
simulated at 10. Adapted from Wack, 2012. 
 
 
Noise Reduction 
In CTP the measure signal due to the contrast agent can be very low. In 
some cases an enhancement of 10 HU or lower can be seen between contrast 
and surrounding tissue (Fieselmann, 2011). Given that the signal is on the order 
of the sample noise, reconstructed images and therefore parameter calculations, 
will demonstrate low signal to noise ratios (SNR). Various techniques, ranging 
from simple to sophisticated, exist to minimize noise thereby increasing SNR. By 
re-writing our least squares solution above to include the singular values in the 
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denominator we see that the term u*c/s is a proportionality factor for the vector vi 
(Fieselmann, 2011). 
.
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A filter should be applied such that the influence of small singular values, and in 
turn, large weighting factors for vi, is minimized (Fieselmann, 2011). The most 
common approach to regularizing the solution to R is by simple binary truncation 
(Fig 3) of the singular value matrix. Such an approach, labeled as truncated 
singular value decomposition (TSVD) sets singular values below an indicated 
threshold (λ) to zero, removing them from calculation and those values equal to 
or above the threshold to 1.  
G,'H  I 0, B 4 λ 1, B 2 λ5 
The selection of the regularization threshold λ is subjective, though most often 
selected relative to the largest singular value, s1 (Fieselmann, 2011) with the 
relative threshold falling between 0 and 1. 
λ  λ
'BE 
A more advanced approach to determining the threshold for truncation is based 
on the observed oscillations inherent in the residue function R(t). An index 
describing the intensity of these oscillations is defined (Ostergaard, 1996) after 
which the truncation is varied until the resulting index of oscillation falls to an 
accepted value. In commercial applications, while these steps are implemented, 
little information is available on the nature of the techniques used, either for 
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reasons of propriety or simplicity. Furthermore some manufacturers utilize 
simplistic fixed thresholds (Kudo, 2010) which may not be dynamic enough for 
consistent accuracy.  
It is appropriate to address a large factor of noise external to the system, 
the patient. An ideal target would remain stationary throughout the duration of the 
image acquisition as voxels represent fixed space within the scanning area. 
Patient motion results in a variation in the attenuation measured in a given voxel 
due to the tissue shifting from its established point in space. One common 
approach to correcting for motion is to register latter scans with respect to time, 
onto the first frame in the series (Smith, 2000).  
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Aims and Objectives 
 
The aim of the following study is to improve output in imaging studies 
which use CT perfusion. Specifically we seek to reduce noise in the raw data. 
This will allow for improved visualization of the calculated parameters. In addition 
to this ultimate goal we seek to implement our changes in a way which promotes 
clinical use. This presents objectives relating to speed of calculation for both our 
method and the total processing time, as well as minimizing the presentation of 
any bias introduced via the new calculations. Bias will be monitored through an 
analysis of mean calculated values while noise reduction is indicated by lowering 
of the standard deviation within the data set. 
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Methods 
 
Patient Selection 
  A set of 10 patients were selected for this study from the pool of patients 
presenting to the University at Buffalo Neurosurgery stroke team. Having 
presented with stroke symptoms, these patients underwent subsequent perfusion 
imaging. Some patient files included multiple perfusion studies performed as 
follow-ups. The follow-up period was generally between 12 hours and 2 days 
from first presentation. As such these scans were included with the original data 
as separate events resulting in a sample size of 15 data sets.   
Data Acquisition 
Patient imaging was performed on a Toshiba Aquilion One 320 slice 
scanner. At the time of imaging the scanner settings were as follows. Peak X-ray 
tube voltage was set to 80 kVp; X-ray tube current set at 350 mA with a 262 mAs 
exposure over 748.6 ms. Data was collected over a 240 mm diameter with a 
revolution time of 0.75 s. The contrast used to perform the perfusion imaging was 
Omnipaque 350 (Iohexol 755mg/mL) manufactured by GE Healthcare. All 
imaging data was anonymized prior to collection. 
Processing 
Before manipulating the image data, patient scans were stripped of all identifying 
information. Upon obtaining the anonymized image data the methodology was 
applied beginning with preprocessing. Image data was converted to the 
Neuroimaging Informatics Technology Initiative (NIfTI) format. The NIfTI format 
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was developed as a replacement to the Analyze format which kept no inherent 
data relevant to orientation of the image (Neuroimaging Informatics Technology 
Initiative, 2004). The NIfTI format does not include time data for the image 
frames, this information was striped form the dicom files and stored as a 
separate variable for tracking. The dynamic frames of patient images were 
aligned within the Statistical Parametric Mapping package (SPM8, Wellcome 
Trust Centre for Neuroimaging, London) built for MATLAB® (MathWorks, Natick, 
MA) and the cSVD noise reduction method was applied. Realignment was 
performed without the mean value and with flags set for quality at 0.9, full width 
and half max (FWHM) at 1.0, and separation at 2.0. FWHM realignment was set 
to 1mm due to the inherently high resolution of CT imaging; this contributes 
greatly to the time of the overall parameter calculation.  A CT template image 
matching the Montréal Neurological Institute (MNI) template was spatially 
normalized to the patient’s image space using routines from SPM8.   Oversized 
regions of interest (ROIs) created on the template image of the middle cerebral 
artery and Saggital Sinus were spatially normalized to the patient space.  The 
arterial input function and venous output function were then selected within the 
voxels of the corresponding ROIs. Thresholding and erosion routines were used 
to minimize partial volume effects. The VOF serves its greatest purpose as a 
check to the AIF, setting a minimum threshold for the AIF values as the peak 
output should not exceed the input given that any bolus should principally 
disperse when passed through the arteries, capillaries, and veins.   
  39
 Noise reduction begins with smoothing the original data with a 3x3x3 mm 
Gaussian kernel. After which, the cSVD method is applied. The cSVD method 
applies the Hilbert Transform to the data set prior to use of singular value 
decomposition. The Hilbert Transform converts the real values of the imaging 
data to the complex plane. If the imaging data from a patient scan is represented 
by matrix A, such that each row consists of a single voxel whose column values 
represent the dynamic frames of the image, then a new matrix Y is created by 
applying the Hilbert Transform to the columns of A.( By working with the complex 
values we(grant the basis functions to have time shifts and mimic arrival times. 
=  7 K L7  
H represents the Hilbert Transform operator and i = √-1. The Hilbert Transform 
maintains the amplitude of each component of the original matrix however it 
shifts the phase of each component ahead by π/2 or 90˚ (Horel, 1984). The 
Hilbert Transform does not reduce the initial noise in any form in and of itself. 
However, when applied it results in a simple method for movement to and from 
the complex plane. Thereafter, the singular value decomposition method 
described in the theory above was applied to the data.  
=  >?@  A "BC@DE  
The most important distinction in this study is that the entirety of the cSVD 
method is applied prior to generation of the parametric data which will be carried 
out using the maximum slope method also outlined above. In this way, the entire 
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data set is decomposed at once allowing all TACs to be expressed with only a 
few basis functions. We truncate the singular values, si, to 3 values. As 
mentioned previously the singular values appear in descending order with the 
magnitude of the first few terms dominating the remainder. This allows 
determination of a truncation point to be simply taken at the point where the 
decreasing magnitude of the singular values reaches a semi-steady state. The 
rank r matrix, Yr , remains a close approximation to the matrix Y, with better 
signal to noise characteristics. 
Analysis 
Three separate regions of interest (ROI) were defined for analysis. In 
order to sample the efficacy of the cSVD method across the entirety of the brain 
tissue, ROIs were segmented from areas of grey matter, white matter, and 
cerebrospinal fluid (CSF). The cortical region of the cerebellum was chosen as a 
representative section of grey matter, cerebral white matter from both the left and 
right hemisphere was taken as representative sample of white matter, and the 
lateral and third ventricles as a sample of cerebrospinal fluid. In localizing these 
regions, three probability maps were generated within SPM8. These probability 
maps were used to confirm the tissue composition of the ROIs and their 
placement. The ROIs used for analysis were drawn on structural CT images 
acquired during the imaging study which also included perfusion measurements. 
The ROIs were placed in the center of the target regions to avoid edge effects. 
For example, rather than covering the lateral ventricles, a sample was selected 
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from well within its bounds (Fig 4). ROIs were drawn using MRIcron software 
version 6.6 (McCausland Center for Brain Imaging, Columbia, SC) and converted 
to the NIfTI format from the native .VOI files. Statistical data from the ROI 
analysis was recorded in (Table 5, 6). 
 
Fig 7. – Selected ROIs of CSF, GM, WM (right to left). 
 
The collected values include the mean and standard deviation for cerebral 
blood volume and cerebral blood flow maps generated for each patient. The 
parametric values mean transit time and time to peak were left out of statistical 
analysis given their dependence on the ratio of CBV and CBF values.   
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Results 
 
 Statistical data was collected with respect to the voxels within the regions 
of interest. Data collected included the mean values, and the standard deviation 
for the cluster of voxels. Analysis was carried out on these values (Table 5, 6).
 In evaluating our initial hypothesis, we expected to see an overall 
decrease in the standard deviation, i.e. noise, of the data. Additionally we 
expected to find no change in the mean values between the standard processing 
and application of our cSVD noise reduction method. No change in the mean 
value indicates the presence of minimal bias. That is, our method has not 
affected the perfusion values calculated, only reduced the noise within the data 
set. The standard deviation of the segmented grey matter, white matter, and CSF 
regions was found to decrease, with statistical significance (p < 0.01), in 
calculations of both blood volume and blood flow. Significant change was 
evaluated through a paired samples T-test. Grey matter samples displayed an 
average decrease in noise (SD) of 0.003 mL/100g and 0.07 mL/100g/min in CBV 
and CBF respectively. White Matter noise (SD) decreased on average 0.004 
mL/100g and 0.07 mL/100g/min, while noise of CSF (SD) samples was reduced 
by 0.005 mL/100g and 0.07 mL/100g/min on average. 
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 ∆ Mean CBV  
GM CSF WM 
0.0002 (0.472) -0.00501 (0.001) -0.00066 (0.281) 
 
 ∆ SD CBV  
GM CSF WM 
-0.00337 (0.00293) -0.00477 (0.0001) -0.00413 (0.0005) 
Table 5 - Average change in mean and standard deviation for CBV – value (p-value) 
 ∆ Mean CBF  
GM CSF WM 
-0.279 (7.3E-7) -0.287 (4.1E-8) -0.229 (4.3E-8) 
 
 ∆ SD CBF  
GM CSF WM 
-0.0731(5.3E-6) -0.0743 (0.0001) -0.0737 (4.7E-6) 
 Table 6 - Average Change in mean and standard deviation for CBF – value (p-value) 
 
 Statistical analysis was performed to elucidate the significance of the 
changes produced by the cSVD method. Significance was determined to be 
positive in three out of four scenarios. In calculations of CBV, measures of the 
mean, between the standard condition and the cSVD condition, were determined 
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to not be statistically significant in samples of GM and WM. In CSF samples, the 
test proved statistical significance between the conditions, with CBV values 
moving closer to 0 than those without cSVD processing. All three ROI samples of 
CBV were determined to be statistically significant with respect to the standard 
deviation (i.e. noise). In calculations of CBF, GM, WM, and CSF regions all 
displayed highly significant changes with regards to reduction of the standard 
deviation. 
  
Fig 8 – Comparison of noise before and after cSVD in CBV-GM 
 
Fig 9 - Comparison of noise before and after cSVD in CBV-CSF 
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Fig 10 - Comparison of noise before and after cSVD in CBV-WM 
 
Fig 11 – Comparison of noise before and after cSVD in CBF-GM 
 
Fig 12 - Comparison of noise before and after cSVD in CBF-CSF 
0
0.01
0.02
0.03
0.04
1 2 3 4 5 6 7 8 9 101112131415
S
t
a
n
d
a
r
d
 D
e
v
ia
t
io
n
Scan Number
Noise Reduction in CBV - WM
WM
WMcsvd
0
0.2
0.4
0.6
0.8
1
1 2 3 4 5 6 7 8 9 101112131415
S
t
a
n
d
a
r
d
 D
e
v
ia
t
io
n
Scan Number
Noise Reduction in CBF - GM
GM
GMcsvd
0
0.05
0.1
0.15
0.2
0.25
0.3
0.35
1 2 3 4 5 6 7 8 9 101112131415
S
t
a
n
d
a
r
d
 D
e
v
ia
t
io
n
Scan Number
Noise Reduction in CBF - CSF
CSF
CSFcsvd
  46
 
Fig 13 - Comparison of noise before and after cSVD in CBF-WM 
 
The mean between the standard and cSVD conditions in CBF 
measurements displayed statistically significant decreases in all three sample 
regions, representing the presence of a downward trending bias. Execution of the 
cSVD algorithm was found to require approximately 2 additional minutes for an 
individual data set.   
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Discussion 
Effectiveness of noise reduction 
 The cSVD noise reduction method was effective in reducing sample noise. 
Using the standard deviation as a measure of noise level, we observed 
reductions in all categories. Both cerebral blood volume and cerebral blood flow 
displayed effective noise reduction (p < 0.01) across samples of grey and white 
tissue as well as CSF.  
Level of Bias 
 Bias was minimal in the CBV values. As expected, the cSVD method 
maintained the mean blood volume values while effectively reducing data noise. 
The CBV-CSF sample paired T-test gave results indicating that the reduction in 
the mean value was statistically significant from the standard processing method. 
When measuring blood volume and blood flow, a sample taken within the 
cerebral spinal fluid should register zero. Therefore the cSVD method is more 
accurate than the standard method in CSF blood volume calculations.  
In the blood flow calculations large bias can be seen in individual 
measures. In any given image set, the mean values of the cSVD data display 
universally lower values as compared to the non-cSVD data. This observation 
may be explained by the effectiveness of the cSVD noise reduction on the data. 
The algorithm selecting the slope within a given voxel is sensitive to the level of 
noise. By reducing the noise we inadvertently reduced the maximum slope of the 
line of best fit within the voxel. Hence, calculations of the CBF, being based on 
  
slope, similarly decreased.
performed simulations (Fig 11). CBF values created at 0.4 and
subjected to noise variance of 5.0, 10.0, and 20.0. Effects of increasing noise 
within the data caused measured CBF values to increase.
 
Fig 14
 
Results of the simulated CBF values 
in the original data. Further inquiry will be undertaken into the effect of the cSVD 
method on CBF bias specifically.
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 This hypothesis has support from previously 
 0.8 were 
 
 – Simulation of Effect of Increasing Noise on CBF Values 
were consistent with the effects seen 
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Clinical Feasibility 
 As discussed throughout the introduction, time is one of the most 
important considerations in the pre-treatment window for cases of acute stroke. 
To this end the clinical feasibility of any imaging modality and its processing is 
limited by its overall time. The purposed cSVD method has been measured at 
two minutes run time. Standard processing times averageabout 5 minutes. This 
value would decrease with use of dedicated processing equipment. Therefore the 
additional processing time would be well spent in producing higher quality 
images used as diagnostic tools for physicians planning acute stroke treatment  
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APPENDICES 
1. Complete Data Set 
 
 
CBV
MEANS Avg Change
GM GMcSVD Δmean CSF CSFcsvd Δmean WM WMcsvd Δmean GM CSF WM
0.0239 0.029 0.0051 0.0188 0.0126 -0.0062 0.0183 0.0205 0.0022 pt1 0.0002 -0.00501 -0.00066
0.0346 0.0394 0.0048 0.0135 0.0125 -0.001 0.0194 0.0248 0.0054 pt2
0.0401 0.0358 -0.0043 0.0161 0.0103 -0.0058 0.0184 0.0142 -0.0042 pt3 STATS
0.0373 0.0394 0.0021 0.0146 0.013 -0.0016 0.0198 0.0196 -0.0002 Pvalue Paried T test
0.0275 0.0325 0.005 0.0105 0.0098 -0.0007 0.0217 0.0212 -0.0005 0.472129 GM
0.0017 0.002 0.0003 0.002 0.001 -0.001 0.005 0.006 0.001 0.001035 CSF
0.053 0.0603 0.0073 0.0138 0.0108 -0.003 0.0179 0.0251 0.0072 0.280545 WM
0.048 0.039 -0.009 0.088 0.0716 -0.0164 0.0449 0.0433 -0.0016 >Not Significantly different
0.045 0.033 -0.012 0.0099 0.0086 -0.0013 0.0233 0.0156 -0.0077
0.0655 0.0645 -0.001 0.0217 0.0099 -0.0118 0.0203 0.0159 -0.0044
0.0761 0.0602 -0.0159 0.0208 0.0107 -0.0101 0.0233 0.0239 0.0006
0.0587 0.0523 -0.0064 0.009 0.0088 -0.0002 0.0208 0.0172 -0.0036
0.0844 0.0855 0.0011 0.0185 0.014 -0.0045 0.0257 0.03 0.0043
0.0538 0.0848 0.031 0.0298 0.0184 -0.0114 0.06 0.0534 -0.0066
0.03 0.0249 -0.0051 0.0095 0.0093 -0.0002 0.0289 0.0271 -0.0018
SD Avg Change
GM GMcSVD Δsd CSF CSFcsvd Δsd WM WMcsvd Δsd GM CSF WM
0.0127 0.0072 -0.0055 0.0179 0.0098 -0.0081 0.0108 0.0048 -0.006 pt1 -0.00337 -0.00477 -0.00413
0.016 0.012 -0.004 0.0142 0.0119 -0.0023 0.011 0.0079 -0.0031 pt2
0.0143 0.0149 0.0006 0.0225 0.0158 -0.0067 0.0097 0.007 -0.0027 pt3 STATS: P-Values of paried T test
0.0141 0.0116 -0.0025 0.0142 0.0119 -0.0023 0.0105 0.0053 -0.0052 0.00293 GM
0.0111 0.008 -0.0031 0.0127 0.0099 -0.0028 0.0111 0.0053 -0.0058 0.000125 CSF
0.0028 0.003 0.0002 0.002 0.002 0 0.004 0.004 0 0.000517 WM
0.0198 0.0159 -0.0039 0.0125 0.0095 -0.003 0.0136 0.0099 -0.0037 > Statisticaly Significant
0.0235 0.0137 -0.0098 0.0538 0.0448 -0.009 0.0266 0.0215 -0.0051
0.025 0.0258 0.0008 0.0122 0.0096 -0.0026 0.0134 0.0109 -0.0025
0.0266 0.0261 -0.0005 0.0219 0.0133 -0.0086 0.0127 0.0103 -0.0024
0.0307 0.0317 0.001 0.0177 0.01 -0.0077 0.0127 0.0082 -0.0045
0.0175 0.0155 -0.002 0.0111 0.0098 -0.0013 0.0129 0.0098 -0.0031
0.1076 0.0941 -0.0135 0.0159 0.0129 -0.003 0.0182 0.0158 -0.0024
0.0375 0.0329 -0.0046 0.0344 0.0213 -0.0131 0.0344 0.0181 -0.0163
0.0207 0.0169 -0.0038 0.0107 0.0097 -0.001 0.0157 0.0165 0.0008
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CBF
Means
GM GMcsvd Δmean CSF CSFcsvd Δmean WM WMcsvd Δmean Avg change
0.4951 0.2388 -0.2563 0.4173 0.1505 -0.2668 0.4485 0.1838 -0.2647 pt1 GM CSF WM
0.5367 0.3458 -0.1909 0.4386 0.1875 -0.2511 0.3998 0.1959 -0.2039 pt2 -0.27929333 -0.28747 -0.22929
0.5158 0.3096 -0.2062 0.3477 0.1054 -0.2423 0.3448 0.1566 -0.1882 pt3
0.4281 0.27 -0.1581 0.3065 0.1118 -0.1947 0.315 0.1353 -0.1797 STATS Paried T test
0.3745 0.2231 -0.1514 0.3151 0.095 -0.2201 0.3163 0.1443 -0.172 7.33031E-07 GM
0.196 0.095 -0.101 0.172 0.054 -0.118 0.146 0.068 -0.078 4.09769E-08 CSF
0.7907 0.4433 -0.3474 0.4916 0.1334 -0.3582 0.4795 0.256 -0.2235 4.309E-08 WM
0.5859 0.1942 -0.3917 0.7555 0.2653 -0.4902 0.5621 0.2167 -0.3454 >Statistically significant
0.7606 0.3995 -0.3611 0.5568 0.2401 -0.3167 0.5766 0.2891 -0.2875
0.8005 0.3784 -0.4221 0.5605 0.2511 -0.3094 0.51 0.2213 -0.2887
0.9685 0.3655 -0.603 0.6544 0.1704 -0.484 0.6037 0.1799 -0.4238
0.67 0.4434 -0.2266 0.4231 0.0887 -0.3344 0.4148 0.1985 -0.2163
1.0352 0.6777 -0.3575 0.4791 0.1474 -0.3317 0.453 0.2115 -0.2415
0.361 0.2374 -0.1236 0.2479 0.1449 -0.103 0.2329 0.1384 -0.0945
0.5579 0.2654 -0.2925 0.4091 0.1176 -0.2915 0.4031 0.1715 -0.2316
SD
GM GMcsvd Δsd CSF CSFcsvd Δsd WM WMcsvd Δsd Avg change
0.1497 0.0588 -0.0909 0.1445 0.095 -0.0495 0.1462 0.0386 -0.1076 pt1 GM CSF WM
0.1588 0.1038 -0.055 0.1465 0.0893 -0.0572 0.121 0.0752 -0.0458 pt2 -0.07307333 -0.07434 -0.07374
0.1436 0.0899 -0.0537 0.132 0.088 -0.044 0.1027 0.0295 -0.0732 pt3
0.1176 0.0806 -0.037 0.1165 0.0854 -0.0311 0.0899 0.0313 -0.0586 STATS: P-Values of paried T test
0.0946 0.0511 -0.0435 0.115 0.0654 -0.0496 0.0898 0.0376 -0.0522 5.31698E-06 GM
0.054 0.039 -0.015 0.058 0.037 -0.021 0.044 0.033 -0.011 0.000138003 CSF
0.2012 0.0891 -0.1121 0.1621 0.0514 -0.1107 0.1501 0.0518 -0.0983 4.74417E-06 WM
0.1605 0.0464 -0.1141 0.3286 0.0861 -0.2425 0.2083 0.0469 -0.1614 > Statisticaly Significant
0.2972 0.1821 -0.1151 0.1659 0.1067 -0.0592 0.1698 0.1031 -0.0667
0.2045 0.1409 -0.0636 0.1947 0.1469 -0.0478 0.1796 0.0993 -0.0803
0.3418 0.164 -0.1778 0.2291 0.0858 -0.1433 0.1919 0.0486 -0.1433
0.1404 0.0762 -0.0642 0.152 0.046 -0.106 0.1247 0.0392 -0.0855
0.8831 0.8362 -0.0469 0.1559 0.0784 -0.0775 0.1339 0.0716 -0.0623
0.328 0.2978 -0.0302 0.1015 0.1083 0.0068 0.0758 0.071 -0.0048
0.1627 0.0857 -0.077 0.1335 0.051 -0.0825 0.1221 0.067 -0.0551
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